Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 10Unknown 5Terminated 4Withdrawn 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Treatment 1Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 315Cyclophosphamide 295pembrolizumab 281Cisplatin 267Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 204Bevacizumab 186Gemcitabine 178venetoclax 172Radiosurgery 169Capecitabine 164Oxaliplatin 163fludarabine 161Nivolumab 156Paclitaxel 155Standard of Care 136Surveys and Questionnaires 130Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104Azacitidine 101atezolizumab 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all
NCT06682117 2026-04-02

Neo-DCV-001

Fudan University

Phase NA Recruiting
9 enrolled
Other solid neoplasm

Treatment

NCT05000801 2021-08-20

Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia

Affiliated Hospital to Academy of Military Medical Sciences

Phase NA Recruiting
20 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡